87
Participants
Start Date
May 31, 1999
Primary Completion Date
December 31, 2006
Study Completion Date
December 31, 2006
Individual Placement and Support
Supported education/employment
Workplace Fundamentals Module
Group skills training on job/school topics
Brokered Vocational Rehabilitation
Vocational rehabilitation through traditional separate state-funded agency
Oral risperidone
Risperidone, starting target dosage was 6 mg, adjusted to level judged optimal by treating psychiatrist
Skills training group
Group social skills training that did not focus primarily on work situations
UCLA Neuropsychiatric Institute, Los Angeles
National Institute of Mental Health (NIMH)
NIH
University of California, Los Angeles
OTHER